|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
AstraZeneca |
|---|---|
| Information provided by: | AstraZeneca |
| ClinicalTrials.gov Identifier: | NCT00786773 |
Purpose
To describe the change of impact of reflux symptoms on the everyday life perceived by patients before and after 4 weeks treatment by using GERD Impact Scale questionnaire (GIS) by total GERD patient population and by treatment group; and to describe the concordance between patient-reported and physician-reported symptom load.
| Condition |
|---|
|
Gastroesophageal Reflux Disease |
| Study Type: | Observational |
| Study Design: | Prospective |
| Official Title: | Epidemiological Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment |
| Estimated Enrollment: | 2055 |
| Study Start Date: | September 2008 |
| Estimated Study Completion Date: | March 2009 |
| Groups/Cohorts |
|---|
|
1
GERD patients who will be treated for GERD with PPI, H2RA, antacid, prokinetics, combination therapy
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
The target survey population is existing GERD patients or newly diagnosed GERD patients, who will be treated for GERD with PPI, H2RA, antacid, prokinetics, combination therapy ... at Visit 1 and will come back after 4 weeks for clinical re-assessment (Visit 2)
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: AstraZeneca Vietnam Clinical Study Information | 84-8-3827 8088 | vanphuc.le@astrazeneca.com |
| Vietnam | |
| Research Site | Not yet recruiting |
| Ca mau, Vietnam | |
| Research Site | Not yet recruiting |
| Can Tho, Vietnam | |
| Research Site | Not yet recruiting |
| Danang, Vietnam | |
| Research Site | Not yet recruiting |
| Haiphong, Vietnam | |
| Research Site | Not yet recruiting |
| Thai binh, Vietnam | |
| Research Site | Recruiting |
| HCMC, Vietnam | |
| Research Site | Not yet recruiting |
| My Tho, Vietnam | |
| Research Site | Not yet recruiting |
| Nam dinh, Vietnam | |
| Research Site | Recruiting |
| Hanoi, Vietnam | |
| Vietnam, An giang | |
| Research Site | Not yet recruiting |
| Long xuyen, An giang, Vietnam | |
| Vietnam, Binh dinh | |
| Research Site | Not yet recruiting |
| Qui nhon, Binh dinh, Vietnam | |
| Vietnam, Dac Lac | |
| Research Site | Not yet recruiting |
| Ban Me Thuot, Dac Lac, Vietnam | |
| Vietnam, Dong Nai | |
| Research Site | Not yet recruiting |
| Bien Hoa, Dong Nai, Vietnam | |
| Research Site | Not yet recruiting |
| Thong nhat, Dong Nai, Vietnam | |
| Vietnam, Dong Thap | |
| Research Site | Not yet recruiting |
| Cao Lanh, Dong Thap, Vietnam | |
| Research Site | Not yet recruiting |
| Sa Dec, Dong Thap, Vietnam | |
| Vietnam, Khanh hoa | |
| Research Site | Not yet recruiting |
| Nha trang, Khanh hoa, Vietnam | |
| Vietnam, Thua thien Hue | |
| Research Site | Not yet recruiting |
| Hue, Thua thien Hue, Vietnam | |
| Principal Investigator: | Ta Long | Vietnam Association of Gastroenterology |
| Principal Investigator: | Dao Van Long | Medical University of Hanoi |
| Principal Investigator: | Tran Kieu Mien | HCMC Association of Gastroenterology |
| Principal Investigator: | Le Thanh Ly | Cho Ray hospital |
More Information
| Responsible Party: | AstraZeneca Pharmaceuticals ( Le Van Phuc ) |
| Study ID Numbers: | NIS-GVN-DUM-2008/1 |
| Study First Received: | November 5, 2008 |
| Last Updated: | November 5, 2008 |
| ClinicalTrials.gov Identifier: | NCT00786773 |
| Health Authority: | Vietnam: Ministry of Health |
|
GERD reflux symptom heartburn acid regurgitation |
PPI H2RA antacid |
|
Deglutition Disorders Esophageal Motility Disorders Pyrosis Digestive System Diseases Esophageal disorder |
Gastrointestinal Diseases Heartburn Esophageal Diseases Gastroesophageal Reflux |
